These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 21923668)

  • 1. Target levels of functional C1-inhibitor in hereditary angioedema.
    Hack CE; Relan A; van Amersfoort ES; Cicardi M
    Allergy; 2012 Jan; 67(1):123-30. PubMed ID: 21923668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic analysis of human plasma-derived pasteurized C1-inhibitor concentrate in adults and children with hereditary angioedema: a prospective study.
    Martinez-Saguer I; Rusicke E; Aygören-Pürsün E; von Hentig N; Klingebiel T; Kreuz W
    Transfusion; 2010 Feb; 50(2):354-60. PubMed ID: 19788511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of prophylactic nanofiltered C1-inhibitor in hereditary angioedema.
    Zuraw BL; Kalfus I
    Am J Med; 2012 Sep; 125(9):938.e1-7. PubMed ID: 22800873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial.
    Riedl MA; Bernstein JA; Li H; Reshef A; Lumry W; Moldovan D; Farkas H; Levy R; Baker J; Hardiman Y; Totoritis MC; Relan A; Cicardi M;
    Ann Allergy Asthma Immunol; 2014 Feb; 112(2):163-169.e1. PubMed ID: 24468257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema.
    van Doorn MB; Burggraaf J; van Dam T; Eerenberg A; Levi M; Hack CE; Schoemaker RC; Cohen AF; Nuijens J
    J Allergy Clin Immunol; 2005 Oct; 116(4):876-83. PubMed ID: 16210064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary angioedema: management of laryngeal attacks.
    Christiansen SC; Zuraw BL
    Am J Rhinol Allergy; 2011; 25(6):379-82. PubMed ID: 22185739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human-C1 inhibitor is effective and safe for repeat hereditary angioedema attacks.
    Li HH; Moldovan D; Bernstein JA; Reshef A; Porebski G; Stobiecki M; Baker J; Levy R; Relan A; Riedl M
    J Allergy Clin Immunol Pract; 2015; 3(3):417-23. PubMed ID: 25680925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of recombinant C1 inhibitor in patients with resistant or frequent attacks of hereditary or acquired angioedema.
    Manson AL; Dempster J; Grigoriadou S; Buckland MS; Longhurst HJ
    Eur J Dermatol; 2014; 24(1):28-34. PubMed ID: 24556385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).
    Sabharwal G; Craig T
    Expert Rev Clin Immunol; 2015 Mar; 11(3):319-27. PubMed ID: 25669442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of hereditary angioedema.
    Zuraw BL; Christiansen SC
    Am J Rhinol Allergy; 2011; 25(6):373-8. PubMed ID: 22185738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathophysiology of hereditary angioedema.
    Davis AE
    Clin Immunol; 2005 Jan; 114(1):3-9. PubMed ID: 15596403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks.
    Craig TJ; Levy RJ; Wasserman RL; Bewtra AK; Hurewitz D; Obtułowicz K; Reshef A; Ritchie B; Moldovan D; Shirov T; Grivcheva-Panovska V; Kiessling PC; Keinecke HO; Bernstein JA
    J Allergy Clin Immunol; 2009 Oct; 124(4):801-8. PubMed ID: 19767078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanofiltered human C1 inhibitor concentrate (Cinryze®): in hereditary angioedema.
    Lyseng-Williamson KA
    BioDrugs; 2011 Oct; 25(5):317-27. PubMed ID: 21942916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal C1 inhibitor mRNA expression level in type I hereditary angioedema patients: newly found C1 inhibitor gene mutations.
    Kang HR; Yim EY; Oh SY; Chang YS; Kim YK; Cho SH; Min KU; Kim YY
    Allergy; 2006 Feb; 61(2):260-4. PubMed ID: 16409206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study.
    Moldovan D; Reshef A; Fabiani J; Kivity S; Toubi E; Shlesinger M; Triggiani M; Montinaro V; Cillari E; Realdi G; Cancian M; Visscher S; Zanichelli A; Relan A; Cicardi M
    Clin Exp Allergy; 2012 Jun; 42(6):929-35. PubMed ID: 22909164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventive Treatment of Hereditary Angioedema: A Review of Phase III Clinical Trial Data for Subcutaneous C1 Inhibitor and Relevance for Patient Management.
    West JB; Poarch K; Lumry WR
    Clin Ther; 2021 Dec; 43(12):2154-2166.e1. PubMed ID: 34879971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Icatibant. Attacks of hereditary angioedema: continue to use C1 esterase inhibitor.
    Prescrire Int; 2010 Nov; 19(110):245-7. PubMed ID: 21284353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema.
    Zuraw B; Cicardi M; Levy RJ; Nuijens JH; Relan A; Visscher S; Haase G; Kaufman L; Hack CE
    J Allergy Clin Immunol; 2010 Oct; 126(4):821-827.e14. PubMed ID: 20920772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks--final results of the I.M.P.A.C.T.2 study.
    Craig TJ; Bewtra AK; Bahna SL; Hurewitz D; Schneider LC; Levy RJ; Moy JN; Offenberger J; Jacobson KW; Yang WH; Eidelman F; Janss G; Packer FR; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
    Allergy; 2011 Dec; 66(12):1604-11. PubMed ID: 21884533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 and hereditary angioedema: Incidence, outcomes, and mechanistic implications.
    Veronez CL; Christiansen SC; Smith TD; Riedl MA; Zuraw BL
    Allergy Asthma Proc; 2021 Nov; 42(6):506-514. PubMed ID: 34871158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.